The TOUCH program and risk management plan for the administration of Natalizumab: Updated safety results from the use of Natalizumab in patients with relapsing Multiple Sclerosis and Crohnʼs Disease

Autor:	Carmen Bozic, G Francis, G. Belcher, M Kooijmans, G Hogge, Bruce E. Sands, R Kim, F. Lynn
Rok vydání:	2008
Předmět:	Risk management plan medicine.medical_specialty Crohn's disease business.industry Multiple sclerosis Gastroenterology medicine.disease Natalizumab Internal medicine medicine Immunology and Allergy In patient business Administration (government) Risk management medicine.drug
Zdroj:	Inflammatory Bowel Diseases. 14:S2
ISSN:	1078-0998
DOI:	10.1097/00054725-200812003-00004
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5c576ca78c6de175aaa47b40460797e4 https://doi.org/10.1097/00054725-200812003-00004 Zobrazit plný text záznamu Plný text